Compare, Analyse Pfizer with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TEVA PHARMA (Israel) - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   TEVA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-18
TEVA PHARMA
Dec-13
PFIZER/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,3652,980-   
Low Rs1,6252,589-   
Sales per share (Unadj.) Rs430.31,710.2-  
Earnings per share (Unadj.) Rs78.7106.8-  
Cash flow per share (Unadj.) Rs93.2245.1-  
Dividends per share (Unadj.) Rs20.0093.52-  
Dividend yield (eoy) %1.03.4 29.8%  
Book value per share (Unadj.) Rs586.51,899.7-  
Shares outstanding (eoy) m45.75848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.61.6 284.8%   
Avg P/E ratio x25.326.1 97.3%  
P/CF ratio (eoy) x21.411.4 188.4%  
Price / Book Value ratio x3.41.5 232.1%  
Dividend payout %25.487.5 29.0%   
Avg Mkt Cap Rs m91,2712,361,010 3.9%   
No. of employees `0002.644.9 5.9%   
Total wages/salary Rs m3,1430-   
Avg. sales/employee Rs Th7,484.832,266.5 23.2%   
Avg. wages/employee Rs Th1,195.00-   
Avg. net profit/employee Rs Th1,369.12,015.7 67.9%   
INCOME DATA
Net Sales Rs m19,6851,450,216 1.4%  
Other income Rs m1,1430-   
Total revenues Rs m20,8281,450,216 1.4%   
Gross profit Rs m5,003397,143 1.3%  
Depreciation Rs m663117,222 0.6%   
Interest Rs m428,485 0.0%   
Profit before tax Rs m5,479251,436 2.2%   
Minority Interest Rs m01,142 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,054 0.0%   
Tax Rs m1,878-3,070 -61.2%   
Profit after tax Rs m3,60190,594 4.0%  
Gross profit margin %25.427.4 92.8%  
Effective tax rate %34.3-1.2 -2,808.0%   
Net profit margin %18.36.2 292.8%  
BALANCE SHEET DATA
Current assets Rs m24,167979,471 2.5%   
Current liabilities Rs m9,544854,181 1.1%   
Net working cap to sales %74.38.6 859.8%  
Current ratio x2.51.1 220.8%  
Inventory Days Days5591 60.7%  
Debtors Days Days2996 29.9%  
Net fixed assets Rs m9,514473,673 2.0%   
Share capital Rs m4583,570 12.8%   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,8321,610,915 1.7%   
Long term debt Rs m25741,528 0.0%   
Total assets Rs m36,9003,314,209 1.1%  
Interest coverage x1,305.59.8 13,285.2%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.50.4 121.9%   
Return on assets %9.83.6 271.9%  
Return on equity %13.45.6 238.6%  
Return on capital %20.44.9 414.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,318231,089 1.4%  
From Investments Rs m-2,383-81,884 2.9%  
From Financial Activity Rs m-1,104-277,207 0.4%  
Net Cashflow Rs m-169-128,002 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.39 Rs / USD

Compare PFIZER With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PFIZER With: J.B.CHEMICALS  ELDER PHARMA  AUROBINDO PHARMA  GSK PHARMA  NOVARTIS  



Today's Market

Bank Credit Growth, World Bank on Developments in India, and Top Cues in Focus Today(Pre-Open)

On Thursday, Indian share markets rose sharply during closing hours and ended on a strong note, extending gains to the fifth day.

Related Views On News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 17, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS